Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status now states 'No longer looking for participants', indicating enrollment has ended for the study. The page shows a new 'Revision: v3.6.0' tag reflecting an updated version.SummaryDifference0.3%

- Check20 days agoChange DetectedThe history now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This marks a newer version of the record display.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the page history. This represents a minor maintenance update to the page's documentation and history log.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdated the page’s revision identifier from v3.5.2 to v3.5.3 in the footer, indicating a site/viewer software update rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.5.2 to the history; removed Revision: v3.5.0.SummaryDifference0.1%

- Check98 days agoChange DetectedA new revision entry v3.5.0 was added to the history, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.